Sadeghi E, Vupparaboina S, Bollepalli S, Vupparaboina K, Agarwal K, Sahel J
Graefes Arch Clin Exp Ophthalmol. 2024; 263(1):77-86.
PMID: 39174817
DOI: 10.1007/s00417-024-06605-8.
Strzalka-Mrozik B, Paprzycka O, Gruszka O, Madej M, Kruszniewska-Rajs C, Gola J
J Clin Med. 2024; 13(1).
PMID: 38202302
PMC: 10780024.
DOI: 10.3390/jcm13010295.
McGrady N, Boal A, Risner M, Taiel M, Sahel J, Calkins D
Mol Ther. 2023; 31(7):2005-2013.
PMID: 37016579
PMC: 10362393.
DOI: 10.1016/j.ymthe.2023.03.035.
Akcay E, Delioglu E, Kars M, Demir P, Cagil N
Arq Bras Oftalmol. 2022; .
PMID: 36350908
PMC: 11627091.
DOI: 10.5935/0004-2749.2022-0004.
Chakraborty S, Sheth J
Case Rep Ophthalmol Med. 2022; 2022:3755249.
PMID: 35127189
PMC: 8816604.
DOI: 10.1155/2022/3755249.
A Study on the Drug Concentration in Fellow Eyes After Unilateral Intravitreal Injection of Conbercept Into New Zealand Rabbit Eyes.
Di Y, Xu H, Ye J, Guo Z
Front Pharmacol. 2021; 12:783057.
PMID: 34925038
PMC: 8672112.
DOI: 10.3389/fphar.2021.783057.
Biodistribution of intravitreal nolparvovec gene therapy in nonhuman primates.
Calkins D, Yu-Wai-Man P, Newman N, Taiel M, Singh P, Chalmey C
Mol Ther Methods Clin Dev. 2021; 23:307-318.
PMID: 34729378
PMC: 8526752.
DOI: 10.1016/j.omtm.2021.09.013.
Influence of unilateral intravitreal bevacizumab injection on the incidence of symptomatic choroidal neovascularization in the fellow eye in patients with neovascular age-related macular degeneration (Review).
Branisteanu D, Branisteanu D, Feraru C, Branisteanu C, Moraru A, Zemba M
Exp Ther Med. 2020; 20(6):182.
PMID: 33101472
PMC: 7579776.
DOI: 10.3892/etm.2020.9312.
Evaluation of long-term intravitreal anti-vascular endothelial growth factor injections on renal function in patients with and without diabetic kidney disease.
ONeill R, Gallagher P, Douglas T, Little J, Maxwell A, Silvestri G
BMC Nephrol. 2019; 20(1):478.
PMID: 31878889
PMC: 6933625.
DOI: 10.1186/s12882-019-1650-1.
Retinoblastoma regression following intra-arterial chemotherapy to the contralateral eye.
Su G, Lim L, Welch R, Shields C
Saudi J Ophthalmol. 2019; 33(3):291-293.
PMID: 31686972
PMC: 6819715.
DOI: 10.1016/j.sjopt.2019.05.007.
Effect of intravitreal dexamethasone implant on the contralateral eye in recalcitrant radiation maculopathy.
Gulati S, Pillai G, Radhakrishnan N
Oman J Ophthalmol. 2019; 12(2):129-132.
PMID: 31198302
PMC: 6561037.
DOI: 10.4103/ojo.OJO_68_2016.
Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye.
Isildak H, Schwartz S, Flynn Jr H
Case Rep Ophthalmol Med. 2018; 2018:8561895.
PMID: 29850326
PMC: 5941819.
DOI: 10.1155/2018/8561895.
Gene expression levels of the insulin-like growth factor family in patients with AMD before and after ranibizumab intravitreal injections.
Strzalka-Mrozik B, Kimsa-Furdzik M, Kabiesz A, Michalska-Malecka K, Nita M, Mazurek U
Clin Interv Aging. 2017; 12:1401-1408.
PMID: 28919726
PMC: 5592959.
DOI: 10.2147/CIA.S135030.
Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration.
Michalska-Malecka K, Kabiesz A, Kimsa M, Strzalka-Mrozik B, Forminska-Kapuscik M, Nita M
Clin Interv Aging. 2016; 11:357-65.
PMID: 27069359
PMC: 4818053.
DOI: 10.2147/CIA.S93820.
The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: A comparative study of two anti-VEGFs.
Bakbak B, Ozturk B, Gonul S, Gedik S
Oman J Ophthalmol. 2016; 9(1):44-8.
PMID: 27013828
PMC: 4785708.
DOI: 10.4103/0974-620X.176100.
Posterior sub-tenon's bevacizumab injection in diabetic macular edema; a pilot study.
Falavarjani K, Khadamy J, Moghaddam A, Karimi N, Modarres M
Saudi J Ophthalmol. 2015; 29(4):270-3.
PMID: 26586977
PMC: 4625118.
DOI: 10.1016/j.sjopt.2015.06.002.
Re: 'Fellow eye effect of unilateral intravitreal bevacizumab injection in eyes with diabetic macular edema'.
Sharma N, Ong J, Ooi J
Eye (Lond). 2014; 29(2):291-2.
PMID: 25397780
PMC: 4330279.
DOI: 10.1038/eye.2014.265.
Fellow eye effect of unilateral intravitreal bevacizumab injection in eyes with diabetic macular edema.
Hanhart J, Tiosano L, Averbukh E, Banin E, Hemo I, Chowers I
Eye (Lond). 2014; 28(6):646-53.
PMID: 24858528
PMC: 4058632.
DOI: 10.1038/eye.2014.94.
Serum concentration of vascular endothelial growth factor after bilateral intravitreal injection of bevacizumab.
Wang D, Choi K, Lee S
Korean J Ophthalmol. 2014; 28(1):32-8.
PMID: 24505199
PMC: 3913980.
DOI: 10.3341/kjo.2014.28.1.32.
Novel endogenous glycan therapy for retinal diseases: safety, in vitro stability, ocular pharmacokinetic modeling, and biodistribution.
Swaminathan S, Li H, Palamoor M, de Obarrio W, Madhura D, Meibohm B
AAPS J. 2014; 16(2):311-23.
PMID: 24470212
PMC: 3933590.
DOI: 10.1208/s12248-014-9563-1.